Cargando…
A Humanized Monoclonal Antibody Targeting Extracellular Nicotinamide Phosphoribosyltransferase Prevents Aggressive Prostate Cancer Progression
Prostate cancer (PCa) is the major cause of cancer-related death in males; however, effective treatments to prevent aggressive progression remain an unmet need. We have previously demonstrated that secreted extracellular nicotinamide phosphoribosyltransferase (eNAMPT) is a multifunctional innate imm...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706080/ https://www.ncbi.nlm.nih.gov/pubmed/34959723 http://dx.doi.org/10.3390/ph14121322 |
_version_ | 1784622105471483904 |
---|---|
author | Sun, Belinda L. Tang, Lin Sun, Xiaoguang Garcia, Alexander N. Camp, Sara M. Posadas, Edwin Cress, Anne E. Garcia, Joe G. N. |
author_facet | Sun, Belinda L. Tang, Lin Sun, Xiaoguang Garcia, Alexander N. Camp, Sara M. Posadas, Edwin Cress, Anne E. Garcia, Joe G. N. |
author_sort | Sun, Belinda L. |
collection | PubMed |
description | Prostate cancer (PCa) is the major cause of cancer-related death in males; however, effective treatments to prevent aggressive progression remain an unmet need. We have previously demonstrated that secreted extracellular nicotinamide phosphoribosyltransferase (eNAMPT) is a multifunctional innate immunity regulator that promotes PCa invasion. In the current study, we further investigate the therapeutic effects of an eNAMPT-neutralizing humanized monoclonal antibody (ALT-100 mAb) in preclinical PCa orthotopic xenograft models. We utilized human aggressive PCa cells (DU145 or PC3) for prostate implantation in SCID mice receiving weekly intraperitoneal injections of either ALT-100 mAb or IgG/PBS (control) for 12 weeks. Prostatic tumors and solid organs were examined for tumor growth, invasion, and metastasis and for biochemical and immunohistochemistry evidence of NFκB activation. ALT-100 mAb treatment significantly improved overall survival of SCID mice implanted with human PCa orthotopic prostate xenografts while inducing tumor necrosis, decreasing PCa proliferation and reducing local invasion and distal metastases. The ALT-100 mAb inhibits NFκB phosphorylation and signaling in PCa cells both in vitro and in vivo. This study demonstrates that eNAMPT neutralization effectively prevents human PCa aggressive progression in preclinical models, indicating its high potential to directly address the unmet need for an effective targeted therapy for patients with aggressive PCa. |
format | Online Article Text |
id | pubmed-8706080 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87060802021-12-25 A Humanized Monoclonal Antibody Targeting Extracellular Nicotinamide Phosphoribosyltransferase Prevents Aggressive Prostate Cancer Progression Sun, Belinda L. Tang, Lin Sun, Xiaoguang Garcia, Alexander N. Camp, Sara M. Posadas, Edwin Cress, Anne E. Garcia, Joe G. N. Pharmaceuticals (Basel) Article Prostate cancer (PCa) is the major cause of cancer-related death in males; however, effective treatments to prevent aggressive progression remain an unmet need. We have previously demonstrated that secreted extracellular nicotinamide phosphoribosyltransferase (eNAMPT) is a multifunctional innate immunity regulator that promotes PCa invasion. In the current study, we further investigate the therapeutic effects of an eNAMPT-neutralizing humanized monoclonal antibody (ALT-100 mAb) in preclinical PCa orthotopic xenograft models. We utilized human aggressive PCa cells (DU145 or PC3) for prostate implantation in SCID mice receiving weekly intraperitoneal injections of either ALT-100 mAb or IgG/PBS (control) for 12 weeks. Prostatic tumors and solid organs were examined for tumor growth, invasion, and metastasis and for biochemical and immunohistochemistry evidence of NFκB activation. ALT-100 mAb treatment significantly improved overall survival of SCID mice implanted with human PCa orthotopic prostate xenografts while inducing tumor necrosis, decreasing PCa proliferation and reducing local invasion and distal metastases. The ALT-100 mAb inhibits NFκB phosphorylation and signaling in PCa cells both in vitro and in vivo. This study demonstrates that eNAMPT neutralization effectively prevents human PCa aggressive progression in preclinical models, indicating its high potential to directly address the unmet need for an effective targeted therapy for patients with aggressive PCa. MDPI 2021-12-17 /pmc/articles/PMC8706080/ /pubmed/34959723 http://dx.doi.org/10.3390/ph14121322 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Sun, Belinda L. Tang, Lin Sun, Xiaoguang Garcia, Alexander N. Camp, Sara M. Posadas, Edwin Cress, Anne E. Garcia, Joe G. N. A Humanized Monoclonal Antibody Targeting Extracellular Nicotinamide Phosphoribosyltransferase Prevents Aggressive Prostate Cancer Progression |
title | A Humanized Monoclonal Antibody Targeting Extracellular Nicotinamide Phosphoribosyltransferase Prevents Aggressive Prostate Cancer Progression |
title_full | A Humanized Monoclonal Antibody Targeting Extracellular Nicotinamide Phosphoribosyltransferase Prevents Aggressive Prostate Cancer Progression |
title_fullStr | A Humanized Monoclonal Antibody Targeting Extracellular Nicotinamide Phosphoribosyltransferase Prevents Aggressive Prostate Cancer Progression |
title_full_unstemmed | A Humanized Monoclonal Antibody Targeting Extracellular Nicotinamide Phosphoribosyltransferase Prevents Aggressive Prostate Cancer Progression |
title_short | A Humanized Monoclonal Antibody Targeting Extracellular Nicotinamide Phosphoribosyltransferase Prevents Aggressive Prostate Cancer Progression |
title_sort | humanized monoclonal antibody targeting extracellular nicotinamide phosphoribosyltransferase prevents aggressive prostate cancer progression |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706080/ https://www.ncbi.nlm.nih.gov/pubmed/34959723 http://dx.doi.org/10.3390/ph14121322 |
work_keys_str_mv | AT sunbelindal ahumanizedmonoclonalantibodytargetingextracellularnicotinamidephosphoribosyltransferasepreventsaggressiveprostatecancerprogression AT tanglin ahumanizedmonoclonalantibodytargetingextracellularnicotinamidephosphoribosyltransferasepreventsaggressiveprostatecancerprogression AT sunxiaoguang ahumanizedmonoclonalantibodytargetingextracellularnicotinamidephosphoribosyltransferasepreventsaggressiveprostatecancerprogression AT garciaalexandern ahumanizedmonoclonalantibodytargetingextracellularnicotinamidephosphoribosyltransferasepreventsaggressiveprostatecancerprogression AT campsaram ahumanizedmonoclonalantibodytargetingextracellularnicotinamidephosphoribosyltransferasepreventsaggressiveprostatecancerprogression AT posadasedwin ahumanizedmonoclonalantibodytargetingextracellularnicotinamidephosphoribosyltransferasepreventsaggressiveprostatecancerprogression AT cressannee ahumanizedmonoclonalantibodytargetingextracellularnicotinamidephosphoribosyltransferasepreventsaggressiveprostatecancerprogression AT garciajoegn ahumanizedmonoclonalantibodytargetingextracellularnicotinamidephosphoribosyltransferasepreventsaggressiveprostatecancerprogression AT sunbelindal humanizedmonoclonalantibodytargetingextracellularnicotinamidephosphoribosyltransferasepreventsaggressiveprostatecancerprogression AT tanglin humanizedmonoclonalantibodytargetingextracellularnicotinamidephosphoribosyltransferasepreventsaggressiveprostatecancerprogression AT sunxiaoguang humanizedmonoclonalantibodytargetingextracellularnicotinamidephosphoribosyltransferasepreventsaggressiveprostatecancerprogression AT garciaalexandern humanizedmonoclonalantibodytargetingextracellularnicotinamidephosphoribosyltransferasepreventsaggressiveprostatecancerprogression AT campsaram humanizedmonoclonalantibodytargetingextracellularnicotinamidephosphoribosyltransferasepreventsaggressiveprostatecancerprogression AT posadasedwin humanizedmonoclonalantibodytargetingextracellularnicotinamidephosphoribosyltransferasepreventsaggressiveprostatecancerprogression AT cressannee humanizedmonoclonalantibodytargetingextracellularnicotinamidephosphoribosyltransferasepreventsaggressiveprostatecancerprogression AT garciajoegn humanizedmonoclonalantibodytargetingextracellularnicotinamidephosphoribosyltransferasepreventsaggressiveprostatecancerprogression |